News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
741,981 Results
Type
Article (63214)
Company Profile (490)
Press Release (678261)
Multimedia
Podcasts (150)
Webinars (22)
Section
Business (196186)
Career Advice (3513)
Deals (35472)
Drug Delivery (132)
Drug Development (85454)
Employer Resources (180)
FDA (17587)
Job Trends (15569)
News (344933)
Policy (35031)
Tag
Academia (2932)
Academic (1)
Accelerated approval (18)
Adcomms (35)
Allergies (127)
Alliances (51671)
ALS (145)
Alzheimer's disease (1677)
Antibody-drug conjugate (ADC) (257)
Approvals (17624)
Artificial intelligence (461)
Autoimmune disease (95)
Automation (29)
Bankruptcy (358)
Best Places to Work (12228)
BIOSECURE Act (22)
Biosimilars (164)
Biotechnology (351)
Bladder cancer (138)
Brain cancer (53)
Breast cancer (514)
Cancer (4068)
Cardiovascular disease (352)
Career advice (2993)
Career pathing (38)
CAR-T (252)
CDC (54)
Cell therapy (695)
Cervical cancer (32)
Clinical research (71222)
Collaboration (1421)
Company closure (4)
Compensation (914)
Complete response letters (60)
COVID-19 (2880)
CRISPR (83)
C-suite (608)
Cystic fibrosis (139)
Data (4766)
Decentralized trials (2)
Denatured (49)
Depression (111)
Diabetes (456)
Diagnostics (6702)
Digital health (34)
Diversity (11)
Diversity, equity & inclusion (44)
Drug discovery (219)
Drug pricing (190)
Drug shortages (36)
Duchenne muscular dystrophy (205)
Earnings (77581)
Editorial (55)
Employer branding (23)
Employer resources (160)
Events (118546)
Executive appointments (974)
FDA (20116)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1274)
Gene editing (176)
Generative AI (44)
Gene therapy (558)
GLP-1 (1010)
Government (5123)
Grass and pollen (8)
Guidances (369)
Healthcare (20104)
HIV (47)
Huntington's disease (39)
IgA nephropathy (63)
Immunology and inflammation (246)
Immuno-oncology (22)
Indications (58)
Infectious disease (3123)
Inflammatory bowel disease (190)
Inflation Reduction Act (15)
Influenza (100)
Intellectual property (196)
Interviews (691)
IPO (16659)
IRA (57)
Job creations (3765)
Job search strategy (2419)
Kidney cancer (16)
Labor market (72)
Layoffs (593)
Leadership (37)
Legal (8026)
Liver cancer (92)
Longevity (12)
Lung cancer (586)
Lymphoma (271)
Machine learning (32)
Management (63)
Manufacturing (642)
MASH (144)
Medical device (13869)
Medtech (13893)
Mergers & acquisitions (19735)
Metabolic disorders (1160)
Multiple sclerosis (139)
NASH (23)
Neurodegenerative disease (231)
Neuropsychiatric disorders (62)
Neuroscience (2725)
NextGen: Class of 2025 (7188)
Non-profit (4899)
Now hiring (52)
Obesity (561)
Opinion (313)
Ovarian cancer (139)
Pain (172)
Pancreatic cancer (173)
Parkinson's disease (241)
Partnered (28)
Patents (420)
Patient recruitment (333)
Peanut (57)
People (58292)
Pharmaceutical (92)
Pharmacy benefit managers (28)
Phase I (22145)
Phase II (31220)
Phase III (23463)
Pipeline (2800)
Policy (293)
Postmarket research (2797)
Preclinical (9635)
Press Release (69)
Prostate cancer (202)
Psychedelics (52)
Radiopharmaceuticals (281)
Rare diseases (692)
Real estate (6032)
Recruiting (76)
Regulatory (25546)
Reports (42)
Research institute (2629)
Resumes & cover letters (567)
Rett syndrome (16)
RNA editing (15)
RSV (73)
Schizophrenia (140)
Series A (210)
Series B (159)
Service/supplier (11)
Sickle cell disease (81)
Special edition (26)
Spinal muscular atrophy (167)
Sponsored (42)
Startups (3754)
State (2)
Stomach cancer (17)
Supply chain (98)
Tariffs (91)
The Weekly (99)
Vaccines (1026)
Venture capital (66)
Weight loss (392)
Women's health (54)
Worklife (21)
Date
Today (29)
Last 7 days (791)
Last 30 days (2653)
Last 365 days (32041)
2025 (26690)
2024 (36862)
2023 (41472)
2022 (52684)
2021 (57296)
2020 (55909)
2019 (49201)
2018 (37325)
2017 (34531)
2016 (34400)
2015 (39512)
2014 (32436)
2013 (27959)
2012 (29566)
2011 (29960)
2010 (28316)
Location
Africa (1033)
Alabama (75)
Alaska (7)
Arizona (243)
Arkansas (14)
Asia (44264)
Australia (7598)
California (9471)
Canada (2871)
China (923)
Colorado (396)
Connecticut (418)
Delaware (264)
Europe (101069)
Florida (1414)
Georgia (298)
Hawaii (2)
Idaho (62)
Illinois (787)
India (51)
Indiana (461)
Iowa (20)
Japan (329)
Kansas (120)
Kentucky (36)
Louisiana (21)
Maine (78)
Maryland (1245)
Massachusetts (7124)
Michigan (295)
Minnesota (546)
Mississippi (4)
Missouri (123)
Montana (33)
Nebraska (26)
Nevada (108)
New Hampshire (78)
New Jersey (2657)
New Mexico (31)
New York (2581)
North Carolina (1370)
North Dakota (10)
Northern California (4359)
Ohio (295)
Oklahoma (21)
Oregon (40)
Pennsylvania (1998)
Puerto Rico (20)
Rhode Island (42)
South America (1356)
South Carolina (49)
South Dakota (1)
Southern California (3640)
Tennessee (141)
Texas (1472)
United States (34778)
Utah (281)
Virginia (239)
Washington D.C. (79)
Washington State (810)
West Virginia (4)
Wisconsin (85)
Wyoming (2)
741,981 Results for "the alliance for regenerative medicine arm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Veristat Joins the Alliance for Regenerative Medicine (ARM) to Help Address Critical Issues Impacting the Advanced Therapy Sector
Veristat, the Science-First Full Service CRO and Consultancy, announced it has joined the Alliance for Regenerative Medicine (ARM), the leading international advocacy organization championing the benefits of cell and gene therapies for patients, healthcare systems, and society.
April 3, 2024
·
3 min read
Press Releases
Kyowa Kirin and Orchard Therapeutics Announce OTL-200 Granted Orphan Regenerative Medicine Product Designation for Early-onset MLD in Japan
October 28, 2025
·
6 min read
FDA
FDA Details Thinking for Streamlining Development of Cell, Gene, Regenerative Therapies
Three draft recommendation documents published on Wednesday are intended to guide drug sponsors and accelerate the development of cell and gene therapies.
September 25, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Medicines Discovery Catapult and Crown Bioscience Form Strategic Global Alliance for Radiopharmaceutical Innovation
September 12, 2025
·
6 min read
Press Releases
Pelage Pharmaceuticals Announces $120 Million Series B Financing to Advance Regenerative Medicine Treatments for Hair Loss
October 16, 2025
·
6 min read
Press Releases
Breakthrough in Patient-Derived Stem Cells for Therapeutic Regenerative Medicine
June 26, 2025
·
2 min read
Press Releases
Celularity and DefEYE, Inc. Partner to Advance Growth of Regenerative Therapies in Eye Care
October 31, 2025
·
5 min read
Press Releases
ExQor Technologies Announces Advancement Toward Clinical Trials for Brain Regenerative Medicine Platform to Treat Alzheimer’s Disease
October 3, 2025
·
3 min read
Press Releases
VeonGen Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for VG801 Gene Therapy for Stargardt Disease
August 22, 2025
·
3 min read
Press Releases
Encoded Therapeutics Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for ETX101 in SCN1A+ Dravet Syndrome
September 2, 2025
·
5 min read
1 of 74,199
Next
